肿瘤性钙化症。 - Suppr

Suppr

超能文献

Tumoral calcinosis.

作者信息

Janssen Mirian C H, de Sévaux Ruud G L

机构信息

Department of General Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.

出版信息

J Inherit Metab Dis. 2010 Feb;33(1):91-2. doi: 10.1007/s10545-009-9019-4. Epub 2010 Jan 5.

DOI:10.1007/s10545-009-9019-4

PMID:20049529

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2828561/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f566/2828561/e2ef0e7b6eb5/10545_2009_9019_Fig1_HTML.jpg

相似文献

Tumoral calcinosis.

J Inherit Metab Dis. 2010 Feb;33(1):91-2. doi: 10.1007/s10545-009-9019-4. Epub 2010 Jan 5.

Elevated serum calcitriol concentrations do not fall in response to hyperphosphatemia in familial tumoral calcinosis.

Am J Dis Child. 1985 Aug;139(8):816-9. doi: 10.1001/archpedi.1985.02140100078036.

Hyperphosphatemic tumoural calcinosis.

BMJ Case Rep. 2016 Jan 25;2016:bcr2015213537. doi: 10.1136/bcr-2015-213537.

Pathogenesis of bone and mineral related disorders in chronic kidney disease: key role of hyperphosphatemia.

J Ren Care. 2009 Mar;35 Suppl 1:34-8. doi: 10.1111/j.1755-6686.2009.00050.x.

Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide.

Bone. 1995 Apr;16(4 Suppl):247S-250S. doi: 10.1016/8756-3282(95)00019-a.

Tumoral calcinosis with vitamin D deficiency.

Saudi J Kidney Dis Transpl. 2008 Nov;19(6):960-3.

Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide.

J Clin Endocrinol Metab. 1980 Apr;50(4):648-53. doi: 10.1210/jcem-50-4-648.

Tumoral calcinosis with hyperphosphatemia.

Indian J Pediatr. 2005 Oct;72(10):889-90. doi: 10.1007/BF02731125.

Calcium and phosphate metabolism in tumoral calcinosis.

Ann Intern Med. 1980 Apr;92(4):482-7. doi: 10.7326/0003-4819-92-4-482.

Hyperphosphatemic tumoral calcinosis: effects of phosphate depletion on vitamin D metabolism, and of acute hypocalcemia on parathyroid hormone secretion and action.

J Clin Endocrinol Metab. 1983 Jun;56(6):1319-22. doi: 10.1210/jcem-56-6-1319.

引用本文的文献

Recurrence of tumoral calcinosis: a case report.

Acta Biomed. 2019 Dec 23;90(4):587-594. doi: 10.23750/abm.v90i4.8251.

Tumoral calcinosis of the foot: An unusual differential diagnosis of calcaneal mass.

Int J Surg Case Rep. 2015;10:219-22. doi: 10.1016/j.ijscr.2015.04.006. Epub 2015 Apr 8.

Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action.

Curr Osteoporos Rep. 2015 Apr;13(2):78-87. doi: 10.1007/s11914-015-0254-3.

Subscapular tumoral calcinosis in a toddler: case report.

J Radiol Case Rep. 2012 Jun;6(6):10-7. doi: 10.3941/jrcr.v6i6.967. Epub 2012 Jun 1.

Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho).

Best Pract Res Clin Rheumatol. 2011 Oct;25(5):735-47. doi: 10.1016/j.berh.2011.10.020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Tumoral calcinosis.

J Inherit Metab Dis. 2010 Feb;33(1):91-2. doi: 10.1007/s10545-009-9019-4. Epub 2010 Jan 5.

Elevated serum calcitriol concentrations do not fall in response to hyperphosphatemia in familial tumoral calcinosis.

Am J Dis Child. 1985 Aug;139(8):816-9. doi: 10.1001/archpedi.1985.02140100078036.

Hyperphosphatemic tumoural calcinosis.

BMJ Case Rep. 2016 Jan 25;2016:bcr2015213537. doi: 10.1136/bcr-2015-213537.

Pathogenesis of bone and mineral related disorders in chronic kidney disease: key role of hyperphosphatemia.

J Ren Care. 2009 Mar;35 Suppl 1:34-8. doi: 10.1111/j.1755-6686.2009.00050.x.

Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide.

Bone. 1995 Apr;16(4 Suppl):247S-250S. doi: 10.1016/8756-3282(95)00019-a.

Tumoral calcinosis with vitamin D deficiency.

Saudi J Kidney Dis Transpl. 2008 Nov;19(6):960-3.

Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide.

J Clin Endocrinol Metab. 1980 Apr;50(4):648-53. doi: 10.1210/jcem-50-4-648.

Tumoral calcinosis with hyperphosphatemia.

Indian J Pediatr. 2005 Oct;72(10):889-90. doi: 10.1007/BF02731125.

Calcium and phosphate metabolism in tumoral calcinosis.

Ann Intern Med. 1980 Apr;92(4):482-7. doi: 10.7326/0003-4819-92-4-482.

Hyperphosphatemic tumoral calcinosis: effects of phosphate depletion on vitamin D metabolism, and of acute hypocalcemia on parathyroid hormone secretion and action.

J Clin Endocrinol Metab. 1983 Jun;56(6):1319-22. doi: 10.1210/jcem-56-6-1319.

引用本文的文献

Recurrence of tumoral calcinosis: a case report.

Acta Biomed. 2019 Dec 23;90(4):587-594. doi: 10.23750/abm.v90i4.8251.

Tumoral calcinosis of the foot: An unusual differential diagnosis of calcaneal mass.

Int J Surg Case Rep. 2015;10:219-22. doi: 10.1016/j.ijscr.2015.04.006. Epub 2015 Apr 8.

Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action.

Curr Osteoporos Rep. 2015 Apr;13(2):78-87. doi: 10.1007/s11914-015-0254-3.

Subscapular tumoral calcinosis in a toddler: case report.

J Radiol Case Rep. 2012 Jun;6(6):10-7. doi: 10.3941/jrcr.v6i6.967. Epub 2012 Jun 1.

Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho).

Best Pract Res Clin Rheumatol. 2011 Oct;25(5):735-47. doi: 10.1016/j.berh.2011.10.020.